Individuals who received J&J, Moderna, or Pfizer-BioNTech vaccine will receive single booster dose of Moderna vaccine 12 to 20 weeks later
NIH Halts Trial of Convalescent Plasma for Mild COVID-19
While the treatment seemed safe, no significant differences in outcomes were seen between patients receiving convalescent plasma or placebo
COVID-19 Vaccines Adapted to Fight Variants Will Not Require Long Clinical Trials: FDA
Most makers of approved COVID-19 vaccines have said they plan to adapt their vaccines to tackle variants
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS
Researchers explore possible anti-inflammatory effects of mesenchymal stem cells in COVID-19 acute respiratory distress syndrome
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
U.S. Food and Drug Administration authorized the restart after reviewing all safety data
U.S. COVID-19 Vaccine Trial Enrolls 30,000
Moderna says it is on track to apply for FDA approval to market the vaccine in early December
Scientists to Infect Volunteers With COVID-19 in Challenge Trial
Challenge trials have long history, going back to development of smallpox vaccine in 1796
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused ‘out of an abundance of caution’
- Page 1 of 2
- 1
- 2